Results of the TIDES study, which screened over 4000 patients and 4500 parents in 9 countries, indicated that our patients and caregivers are at elevated risk for symptoms of depression and anxiety. These symptoms have been shown to affect clinic attendance, adherence, disease management and health outcomes.
The CF Foundation and the European CF Society have commissioned an international committee to establish guidelines for identifying symptoms of depression and anxiety in individuals with CF and parent caregivers.
The committee developed the following survey to answer the questions: "If we were to recommend screening on some regular basis, how would this be integrated into your CF Center? What kinds of resources and structural changes would be helpful?"
Please take 5 minutes to answer the questions included in this survey!
Thank you.